- Investing Ideas
- Swedish Healthcare Undervalued over 20% based on DCF
Swedish Healthcare Undervalued over 20% based on DCF
Results
8
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
8 companies
Getinge
Market Cap: SEK 52.9b
Provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally.
GETI B
SEK 194.35
7D
2.4%
1Y
2.5%
Elekta
Market Cap: SEK 21.1b
A medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
EKTA B
SEK 55.30
7D
3.0%
1Y
10.7%
RaySearch Laboratories
Market Cap: SEK 7.5b
A medical technology company, provides software solutions for cancer treatment worldwide.
RAY B
SEK 219.20
7D
-0.2%
1Y
-33.4%
CellaVision
Market Cap: SEK 3.0b
Develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally.
CEVI
SEK 126.00
7D
4.5%
1Y
-35.1%
Stille
Market Cap: SEK 2.3b
Develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally.
STIL
SEK 251.50
7D
-7.9%
1Y
15.9%
Carasent
Market Cap: SEK 1.5b
Provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany.
CARA
SEK 22.00
7D
-5.6%
1Y
-23.3%
SyntheticMR
Market Cap: SEK 1.2b
Engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally.
SYNT
SEK 27.70
7D
0%
1Y
-13.4%
Mentice
Market Cap: SEK 398.0m
Develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology.
MNTC
SEK 14.15
7D
1.1%
1Y
-32.0%